These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11979839)

  • 1. [Economic evaluation of Helicobacter pylori eradication for peptic ulcer disease in comparison with a conventional strategy in Japan].
    Ohara S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():514-9. PubMed ID: 11979839
    [No Abstract]   [Full Text] [Related]  

  • 2. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H pylori in patients with peptic ulcer disease.
    Strickland C
    J Fam Pract; 1998 Feb; 46(2):117. PubMed ID: 9487314
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacoeconomics in the therapy of peptic ulcer].
    Tesar T; Foltán V; Huorka M
    Ceska Slov Farm; 2002 Mar; 51(2):78-83. PubMed ID: 11928281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
    Fendrick AM; Chernew ME; Hirth RA; Bloom BS
    Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economic evaluation of H. pylori eradication].
    Ikeda S
    Nihon Rinsho; 2003 Jan; 61(1):146-51. PubMed ID: 12607332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].
    Habu Y; Kiyota K; Inokuchi H; Sugano Y; Ko K; Waki S
    Nihon Rinsho; 1999 Jan; 57(1):135-9. PubMed ID: 10036950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eradication of Helicobacter pylori in developing countries].
    Rollán A
    Rev Med Chil; 1997 Aug; 125(8):939-49. PubMed ID: 9567401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
    Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan.
    Tsuji S; Kawano S
    J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications.
    Powell KU; Bell GD; Bolton GH; Burridge SM; Bowden AF; Rameh B; Hart L; Bradley P; Harrison G; Gant PW
    Q J Med; 1994 May; 87(5):283-90. PubMed ID: 7938408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].
    MMW Fortschr Med; 2003 Aug; 145(33-34):55. PubMed ID: 14526577
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical economics review: Helicobacter pylori-associated peptic ulcer disease.
    Bodger K; Daly MJ; Heatley RV
    Aliment Pharmacol Ther; 1997 Apr; 11(2):273-82. PubMed ID: 9146763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
    Søndergaard B; Bytzer P
    Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170
    [No Abstract]   [Full Text] [Related]  

  • 17. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
    Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
    Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Helicobacter pylori eradication therapy for peptic ulcer disease].
    Satoh K; Sugano K
    Nihon Rinsho; 2009 Dec; 67(12):2322-6. PubMed ID: 19999119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.